Jafron Biomedical (300529.SZ) Earnings Analysis
Jafron Biomedical (300529.SZ) next reports earnings on 2026-08-07. It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E 23.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300529.SZ next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.57B |
300529.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-30 | 0.08 CNY | n/a | n/a | n/a |
| 2025-04-15 | 0.0359 CNY | 0.18 CNY | -80.1% | Miss |
| 2025-03-31 | 0.2317 CNY | n/a | n/a | n/a |
| 2024-10-18 | 0.29 CNY | 0.34 CNY | -14.7% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
300529.SZ valuation and analyst view
| Trailing P/E | 23.93 |
|---|---|
| Trailing EPS | 0.71685 CNY |
| Price / book | 3.68 |
| Dividend yield | 3.01% |
| Market cap | 14.02B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jafron Biomedical (300529.SZ)'s next earnings date?
Jafron Biomedical is next scheduled to report on 2026-08-07 and revenue estimate of 0.57B.
Did 300529.SZ beat earnings last quarter?
Consensus estimate data was not available for 300529.SZ's 2025-10-30 report.
What is 300529.SZ's earnings track record?
Over the last 2 reported quarters with consensus data, 300529.SZ beat estimates 0 times (0%).
What is 300529.SZ's current P/E ratio and EPS?
300529.SZ trades at a trailing P/E of 23.93 on trailing EPS of 0.7168478043911903 CNY.
What do analysts rate 300529.SZ?
300529.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.